0001567619-23-006049.txt : 20230512 0001567619-23-006049.hdr.sgml : 20230512 20230512122557 ACCESSION NUMBER: 0001567619-23-006049 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 EFFECTIVENESS DATE: 20230512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoResponse Inc CENTRAL INDEX KEY: 0001655774 IRS NUMBER: 475120470 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-481584 FILM NUMBER: 23914305 BUSINESS ADDRESS: STREET 1: 1124 COLUMBIA STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: (206) 805-1600 MAIL ADDRESS: STREET 1: 1124 COLUMBIA STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001655774 OncoResponse Inc 1124 COLUMBIA STREET SUITE 300 SEATTLE WA WASHINGTON 98104 (206) 805-1600 DELAWARE None None Corporation true Clifford J. Stocks 1124 Columbia Street Suite 300 Seattle WA WASHINGTON 98104 Executive Officer Director Robert J. Lechleider 1124 Columbia Street Suite 300 Seattle WA WASHINGTON 98104 Executive Officer Kamal D. Puri 1124 Columbia Street Suite 300 Seattle WA WASHINGTON 98104 Executive Officer Christopher A. Russell 1124 Columbia Street Suite 300 Seattle WA WASHINGTON 98104 Executive Officer Roberto DePonti 412F Route D'Esch L-2086 None N4 LUXEMBOURG L-2086 Director Steven Gillis 8725 West Higgins Road Suite 290 Chicago IL ILLINOIS 60631 Director Wende Hutton 2765 Sand Hill Road Menlo Park CA CALIFORNIA 94025 Director Ted Koutouzis 1603 Orrington Avenue 13th Floor Evanston IL ILLINOIS 60201 Director John McKearn 101 S. Hanley Road Suite 1850 St. Louis MO MISSOURI 63105 Director Sean McCarthy 151 Oyster Point Blvd Suite 400 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2023-05-01 false true false 0 40000000 13915153 26084847 false 13 0 0 4800000 true The amount reflects payment of accrued and unpaid bonuses from periods prior to the offering and anticipated salary to the listed executive officers and potential bonus payments for the following 24-month period. false OncoResponse Inc Clifford J. Stocks Clifford J. Stocks Chief Executive Officer 2023-05-12